Norcapto (Nortriptyline)

Nortriptyline, the active ingredient in Norcapto, is a tricyclic antidepressant presented as an oral tablet for oral use. It is employed to treat major depressive disorder in adult patients. GNH USA supplies Norcapto as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nortriptyline acts within the central nervous system to alleviate depressive conditions. - Major depressive disorder: reduces depressive symptoms and improves functional capacity in adults. - Depressive symptoms associated with chronic illness: helps manage co‑morbid depression in patients with long‑term health conditions. - Treatment‑resistant depression: may be considered when first‑line antidepressants have been ineffective.

Nortriptyline may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dry mouth: reduced salivation leading to discomfort. - Constipation: slowed gastrointestinal motility. - Drowsiness or sedation: increased sleepiness, especially after initiation. - Weight gain: gradual increase in body weight. - Blurred vision: temporary visual disturbances. - Urinary retention: difficulty emptying the bladder.

Serious or Rare Side Effects: - Cardiac arrhythmia: irregular heart rhythm, potentially life‑threatening. - Seizures: heightened risk in predisposed individuals. - Severe hypotension: sudden drop in blood pressure causing dizziness. - Serotonin syndrome: potentially fatal condition when combined with other serotonergic agents. - Agranulocytosis: marked reduction in white blood cells, increasing infection risk.

Before initiating therapy, clinicians should evaluate specific safety considerations. - Monitor cardiac function: obtain baseline ECG in patients with cardiac history. - Assess suicidal ideation: closely observe patients during early treatment phases. - Avoid abrupt discontinuation: taper dose under medical supervision to prevent withdrawal. - Use cautiously in elderly: increased sensitivity to anticholinergic and sedative effects. - Contraindicated in recent myocardial infarction: risk of arrhythmias. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Nortriptyline can interact with several medication classes, requiring careful management.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of severe serotonin syndrome. - Selective serotonin reuptake inhibitors (SSRIs) and other serotonergic agents: heightened serotonin toxicity. - Other tricyclic antidepressants: additive cardiotoxic effects. - Linezolid or meperidine: increased potential for serotonin syndrome.

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): may raise nortriptyline plasma levels. - Antihistamines and anticholinergics: amplify anticholinergic side effects. - CNS depressants (e.g., alcohol, benzodiazepines): enhance sedation and respiratory depression.